The spine journal : official journal of the North American Spine SocietyOct 22, 2026

Recovery after Neck Spine Surgery in Type 2 Diabetes Patients Using Diabetes Drugs versus Weight-Loss Surgery

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗

Updated Oct 23, 2026

Abstract

Bariatric surgery offers durable weight loss but is associated with surgical and nutritional risks.

Obesity and diabetes may elevate risks during posterior cervical spine surgery.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) could be a non-surgical option for optimizing weight and metabolic status before surgery.
Evidence regarding the use of GLP-1 therapy specifically in spine surgery is limited.

Simplified

Obesity and diabetes can increase perioperative risk, especially in posterior cervical spine surgery. Bariatric surgery provides durable weight loss but carries surgical and nutritional risks, while glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are non-surgical alternatives that may optimize weight and metabolic status preoperatively. Evidence evaluating GLP-1 therapy in spine surgery is limited.

Full Text

Full text is available at the source.

View Full Text ↗

Recovery after Neck Spine Surgery in Type 2 Diabetes Patients Using Diabetes Drugs versus Weight-Loss Surgery

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the glp-1 therapies brief